Literature DB >> 16818388

Retrograde endocannabinoid signaling in the cerebellar cortex.

Patrick K Safo1, Benjamin F Cravatt, Wade G Regehr.   

Abstract

The regulation of Purkinje cell activity is important for motor behavior and motor learning. As the sole output cell of the cerebellar cortex, Purkinje cell firing is controlled by parallel fibers and climbing fiber synapses, and by inhibitory interneurons. Depolarization of Purkinje cells evokes endocannabinoid release that activates cannabinoid CB1 receptors expressed on boutons of its synaptic inputs to transiently decrease neurotransmitter release. In addition, associative activation of the excitatory inputs can liberate endocannabinoids to decrease synaptic strength for a prolonged duration. Here we review the different mechanisms of evoking endocannabinoid release and discuss the physiological role of endocannabinoids in mediating global modulation of synaptic strength, localized short-term associative plasticity and cerebellar long term depression.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16818388     DOI: 10.1080/14734220600791477

Source DB:  PubMed          Journal:  Cerebellum        ISSN: 1473-4222            Impact factor:   3.648


  82 in total

Review 1.  Short-term synaptic plasticity.

Authors:  Robert S Zucker; Wade G Regehr
Journal:  Annu Rev Physiol       Date:  2002       Impact factor: 19.318

2.  Dopamine modulation of state-dependent endocannabinoid release and long-term depression in the striatum.

Authors:  Anatol C Kreitzer; Robert C Malenka
Journal:  J Neurosci       Date:  2005-11-09       Impact factor: 6.167

Review 3.  Endocannabinoids as autoregulatory signaling molecules: coupling to nitric oxide and a possible association with the relaxation response.

Authors:  George B Stefano; Tobias Esch; Patrick Cadet; Wei Zhu; Kirk Mantione; Herbert Benson
Journal:  Med Sci Monit       Date:  2003-04

4.  An endocannabinoid mechanism for stress-induced analgesia.

Authors:  Andrea G Hohmann; Richard L Suplita; Nathan M Bolton; Mark H Neely; Darren Fegley; Regina Mangieri; Jocelyn F Krey; J Michael Walker; Philip V Holmes; Jonathon D Crystal; Andrea Duranti; Andrea Tontini; Marco Mor; Giorgio Tarzia; Daniele Piomelli
Journal:  Nature       Date:  2005-06-23       Impact factor: 49.962

5.  A second endogenous cannabinoid that modulates long-term potentiation.

Authors:  N Stella; P Schweitzer; D Piomelli
Journal:  Nature       Date:  1997-08-21       Impact factor: 49.962

6.  An NMDA receptor/nitric oxide cascade is involved in cerebellar LTD but is not localized to the parallel fiber terminal.

Authors:  Jung Hoon Shin; David J Linden
Journal:  J Neurophysiol       Date:  2005-08-24       Impact factor: 2.714

7.  Endogenous nitric oxide release required for long-term synaptic depression in the cerebellum.

Authors:  K Shibuki; D Okada
Journal:  Nature       Date:  1991-01-24       Impact factor: 49.962

Review 8.  Endocannabinoid-mediated short-term synaptic plasticity: depolarization-induced suppression of inhibition (DSI) and depolarization-induced suppression of excitation (DSE).

Authors:  Marco A Diana; Alain Marty
Journal:  Br J Pharmacol       Date:  2004-04-20       Impact factor: 8.739

9.  Increased mortality, hypoactivity, and hypoalgesia in cannabinoid CB1 receptor knockout mice.

Authors:  A Zimmer; A M Zimmer; A G Hohmann; M Herkenham; T I Bonner
Journal:  Proc Natl Acad Sci U S A       Date:  1999-05-11       Impact factor: 11.205

10.  Cannabinoids decrease excitatory synaptic transmission and impair long-term depression in rat cerebellar Purkinje cells.

Authors:  C Lévénés; H Daniel; P Soubrié; F Crépel
Journal:  J Physiol       Date:  1998-08-01       Impact factor: 5.182

View more
  36 in total

1.  Zones of enhanced glutamate release from climbing fibers in the mammalian cerebellum.

Authors:  Martin Paukert; Yanhua H Huang; Kohichi Tanaka; Jeffrey D Rothstein; Dwight E Bergles
Journal:  J Neurosci       Date:  2010-05-26       Impact factor: 6.167

2.  Differential expression of posttetanic potentiation and retrograde signaling mediate target-dependent short-term synaptic plasticity.

Authors:  Michael Beierlein; Diasynou Fioravante; Wade G Regehr
Journal:  Neuron       Date:  2007-06-21       Impact factor: 17.173

3.  Timing dependence of the induction of cerebellar LTD.

Authors:  Patrick Safo; Wade G Regehr
Journal:  Neuropharmacology       Date:  2007-06-26       Impact factor: 5.250

Review 4.  The cerebellum, cerebellar disorders, and cerebellar research--two centuries of discoveries.

Authors:  Mario Manto
Journal:  Cerebellum       Date:  2008       Impact factor: 3.847

5.  Endocannabinoids gate state-dependent plasticity of synaptic inhibition in feeding circuits.

Authors:  Karen M Crosby; Wataru Inoue; Quentin J Pittman; Jaideep S Bains
Journal:  Neuron       Date:  2011-08-11       Impact factor: 17.173

6.  Developmentally Transient CB1Rs on Cerebellar Afferents Suppress Afferent Input, Downstream Synaptic Excitation, and Signaling to Migrating Neurons.

Authors:  Jesse L Barnes; Claudia Mohr; Caitlin R Ritchey; Chloe M Erikson; Hiroko Shiina; David J Rossi
Journal:  J Neurosci       Date:  2020-07-06       Impact factor: 6.167

7.  Serotonin evokes endocannabinoid release and retrogradely suppresses excitatory synapses.

Authors:  Aaron R Best; Wade G Regehr
Journal:  J Neurosci       Date:  2008-06-18       Impact factor: 6.167

Review 8.  The function of metabotropic glutamate receptors in thalamus and cortex.

Authors:  S Murray Sherman
Journal:  Neuroscientist       Date:  2013-03-04       Impact factor: 7.519

9.  Progressive impairment of cerebellar mGluR signalling and its therapeutic potential for cerebellar ataxia in spinocerebellar ataxia type 1 model mice.

Authors:  Anton N Shuvaev; Nobutake Hosoi; Yamato Sato; Dai Yanagihara; Hirokazu Hirai
Journal:  J Physiol       Date:  2016-09-15       Impact factor: 5.182

10.  Presynaptic cell dependent modulation of inhibition in cortical regions.

Authors:  Afia B Ali
Journal:  Curr Neuropharmacol       Date:  2009-06       Impact factor: 7.363

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.